NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd. financial statements

NeuroSense Therapeutics Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 11.13M20-F
Cash and equivalentsUSD 166K20-F
Total debtUSD 170KEODHD

NeuroSense Therapeutics Ltd. financials on 6ix · NeuroSense Therapeutics Ltd. on 6ix